Achilles Therapeutics Ltd   Report issue

For profit Phase 2
Founded: Stevenage United Kingdom (2016)

Organization Overview

First Clinical Trial
2019
NCT03997474
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Achilles Therapeutics | Achilles Therapeutics Ltd | Achilles Therapeutics UK Limited

Active Ingredients

Drugs in Phase 2 Trials (1)

atl001 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 2)

Lung Neoplasms (Phase 2)

Melanoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1